2001年至2007年七价肺炎球菌结合疫苗（PCV7）在欧洲的使用情况。
Use of seven-valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001-2007.
作者信息
De Carvalho Gomes H, Muscat M, Monnet D L, Giesecke J, Lopalco P L
机构信息
Scientific Advice Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
出版信息
Euro Surveill. 2009 Mar 26;14(12):19159.
The first pneumococcal vaccine targeting the youngest age groups, a seven-valent conjugate vaccine (PCV7), was licensed in Europe in 2001. Since then several European countries have introduced PCV7 in their childhood vaccination schedules.Still, information on vaccination schemes, vaccine uptake and impact of vaccine introduction is scarce in Europe. The following article summarises the characteristics of national pneumococcal vaccination programmes for children in 32 European countries and provides an estimate of vaccine use based on sales data for 22 countries between 2001 and 2007. There were wide variations in the recommended PCV7 vaccination schemes and in PCV7 use.High vaccine uptake was not always related to the presence of a national vaccination programme.
首款针对最年幼年龄组的肺炎球菌疫苗——七价结合疫苗（PCV7）于2001年在欧洲获得许可。自那时起，几个欧洲国家已将PCV7纳入其儿童疫苗接种计划。然而，在欧洲，关于疫苗接种方案、疫苗接种率以及引入疫苗的影响的信息仍然很少。以下文章总结了32个欧洲国家儿童肺炎球菌国家疫苗接种计划的特点，并根据2001年至2007年期间22个国家的销售数据对疫苗使用情况进行了估计。推荐的PCV7疫苗接种方案和PCV7的使用情况存在很大差异。高疫苗接种率并不总是与国家疫苗接种计划的存在相关。
Zotero 插件